Therapeutic frontiers: the potential of RRx-001 and AdAPT-001
Drug Target Review,
In the realm of medical innovation, a paradigm shift often emerges from unexpected sources.
In the realm of medical innovation, a paradigm shift often emerges from unexpected sources.
Published: Mar. 21, 2023 at 6:00 AM CDT|Updated: 14 minutes ago RRx-001 is a small molecule direct NLRP3 inflammasome inhibitor…
Published: Mar. 21, 2023 at 6:00 AM CDT|Updated: 14 minutes ago RRx-001 is a small molecule direct NLRP3 inflammasome inhibitor…
RRx-001 is a small molecule direct NLRP3 inflammasome inhibitor with activity in cancer, neurodegeneration, and other…